Explore
← New search
6 matching publication(s)
Neoadjuvant sintilimab plus chemotherapy in EGFR-mutant NSCLC: Phase 2 trial interim results (NEOTIDE/CTONG2104).
PMID 38897205 · Cell Rep Med · 2024
L1
72/100
Bulk and single-cell characterisation of the immune heterogeneity of atherosclerosis identifies novel targets for immunotherapy.
PMID 36855107 · BMC Biol · 2023
L2
70/100
Bioinformatics and system biology approaches to identify pathophysiological impact of COVID-19 to the progression and severity of neurological diseases.⚑
PMID 34601390 · Comput Biol Med · 2021
L1
69/100
⚑
Identification of TYR, TYRP1, DCT and LARP7 as related biomarkers and immune infiltration characteristics of vitiligo via comprehensive strategies.
PMID 34107850 · Bioengineered · 2021
L1
55/100
Core transcriptional signatures of phase change in the migratory locust.⚑
PMID 31292921 · Protein Cell · 2019
L1
60/100
⚑
Complete Genome Sequencing of Lactobacillus plantarum ZLP001, a Potential Probiotic That Enhances Intestinal Epithelial Barrier Function and Defense Agai
PMID 30542296 · Front Physiol · 2018
L1
68/100